COMMUNIQUÉS West-GlobeNewswire

Krystal Biotech Announces Pricing of $100.0 Million Public Offering of Common Stock
25/06/2019
PITTSBURGH, June 24, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (Nasdaq: KRYS) (the “Company”), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from [...]
PHASTAR Enters Technology Partnership With Medidata
25/06/2019
CAMBRIDGE, Mass. and LONDON, June 24, 2019 (GLOBE NEWSWIRE) -- PHASTAR , a global CRO, announced today that it has entered into a technology partnership with Medidata Solutions, Inc. PHASTAR will deploy several [...]
CB2 Insights Announces Annual General & Special Meeting of Shareholders and Corporate Update
25/06/2019
TORONTO, June 24, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the [...]
Axiom Real-Time Metrics Exhibiting at DIA Global Annual Meeting in San Diego
25/06/2019
TORONTO, June 24, 2019 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services is exhibiting June 24-26, 2019 at DIA’s Global Annual Meeting in San Diego, CA. [...]
NanoVibronix Announces Closing of $3.2 Million Private Placement
24/06/2019
ELMSFORD, N.Y., June 24, 2019 (GLOBE NEWSWIRE) -- NanoVibronix, Inc ., (NASDAQ: NAOV) , a medical device company that produces the PainShield® surface acoustic wave (SAW) device, which utilizes the Company’s proprietary [...]
ERYTECH Announces Immune Modulation Strategic Collaboration with SQZ Biotechnologies
24/06/2019
LYON, France and CAMBRIDGE, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (ERYTECH) (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by [...]
ERYTECH annonce une collaboration stratégique dans l’immunomodulation avec SQZ Biotech
24/06/2019
LYON, France et CAMBRIDGE, Mass., 24 juin 2019 (GLOBE NEWSWIRE) -- Lyon (France), et Cambridge, MA (États-Unis), 24 juin 2019 - ERYTECH Pharma (ERYTECH) (Euronext Paris : ERYP - Nasdaq : ERYP), société biopharmaceutique [...]
Teleflex Incorporated Announces Worldwide Voluntary Recall of Select Hudson RCI® Sheridan® Endotracheal Tubes
24/06/2019
WAYNE, Pa., June 24, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), has announced a worldwide recall of certain lots of Hudson RCI ® Sheridan ® Endotracheal Tubes. The recalled products are designed for [...]
Krystal Biotech Announces Proposed $100 Million Public Offering of Common Stock
24/06/2019
PITTSBURGH, June 24, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech , Inc. (Nasdaq: KRYS) (the “Company”), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from [...]
Imagin Medical Announces Stock Option Grant
24/06/2019
VANCOUVER, British Columbia and BOSTON, June 24, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced that, under its stock option plan, it [...]
Agile Therapeutics Announces FDA Advisory Committee Meeting for its Investigational Transdermal Low-Dose Contraceptive Patch, Twirla® (AG200-15)
24/06/2019
Meeting Scheduled for October 30, 2019 FDA Previously Assigned PDUFA (Prescription Drug User Fee Act) Goal Date is November 16, 2019 PRINCETON, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: [...]
Integra LifeSciences Announces Promotion of Glenn Coleman to Newly-Created Role of Chief Operating Officer and Appointment of Carrie Anderson as Chief Financial Officer
24/06/2019
PLAINSBORO, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced the promotion of Glenn Coleman to the newly- [...]
GENFIT: GENFIT and Terns Pharmaceuticals Announce $228MM Strategic Partnership to Develop and Commercialize Elafibranor in Greater China
24/06/2019
GENFIT and Terns Pharmaceuticals Announce $228MM Strategic Partnership to Develop and Commercialize Elafibranor in Greater China Lille (France), Cambridge (Massachusetts, United States), June 24, 2019 – GENFIT (Nasdaq [...]
GENFIT : GENFIT et Terns Pharmaceuticals annoncent un partenariat stratégique de 228MM$ pour le développement et la commercialisation d’elafibranor en Chine
24/06/2019
GENFIT et Terns Pharmaceuticals annoncent un partenariat stratégique de 228MM$ pour le développement et la commercialisation d’elafibranor en Chine Lille (France), Cambridge (Massachusetts, États-Unis), le 24 juin 2019 [...]
Conatus to Explore Strategic Alternatives and Implement Restructuring Plan
24/06/2019
SAN DIEGO, June 24, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced that the company has engaged Oppenheimer & Co., Inc., as its financial advisor to assist in the exploration and [...]
Conatus Announces Results from ENCORE-LF and ENCORE-PH Phase 2b Clinical Trials in NASH Cirrhosis
24/06/2019
SAN DIEGO, June 24, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced that top-line results from the company’s ENCORE-LF clinical trial of emricasan did not meet its primary endpoint [...]
Nabriva Therapeutics Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application for Lefamulin
24/06/2019
DUBLIN, Ireland, June 24, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious [...]
Eloxx Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
24/06/2019
WALTHAM, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”) (Nasdaq: ELOX) today announced the closing of its underwritten public offering of 3,833,334 shares of its common stock, which [...]
Cytokinetics Announces Preclinical Data for Reldesemtiv to be Presented at the 2019 Annual Cure SMA Conference
24/06/2019
SOUTH SAN FRANCISCO, Calif., June 24, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that two preclinical poster presentations on the addition of reldesemtiv to treatment with SMN [...]

Pages